Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Tempest Therapeutics Inc (TPST)

Tempest Therapeutics Inc (TPST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 47,100
  • Shares Outstanding, K 22,217
  • Annual Sales, $ 0 K
  • Annual Income, $ -29,490 K
  • 60-Month Beta -1.73
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 2.36
Trade TPST with:

Options Overview Details

View History
  • Implied Volatility 140.10% ( +30.07%)
  • Historical Volatility 107.38%
  • IV Percentile 12%
  • IV Rank 12.49%
  • IV High 350.78% on 10/24/23
  • IV Low 110.03% on 07/01/24
  • Put/Call Vol Ratio 0.26
  • Today's Volume 34
  • Volume Avg (30-Day) 324
  • Put/Call OI Ratio 0.25
  • Today's Open Interest 5,774
  • Open Int (30-Day) 6,664

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.47
  • Number of Estimates 4
  • High Estimate -0.37
  • Low Estimate -0.57
  • Prior Year -0.54
  • Growth Rate Est. (year over year) +12.96%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.87 +13.37%
on 06/21/24
3.43 -38.19%
on 06/05/24
-1.20 (-36.14%)
since 05/31/24
3-Month
1.87 +13.37%
on 06/21/24
5.33 -60.23%
on 04/03/24
-2.97 (-58.35%)
since 04/02/24
52-Week
0.17 +1,147.06%
on 10/10/23
9.77 -78.30%
on 10/11/23
+0.85 (+66.93%)
since 06/30/23

Most Recent Stories

More News
MarketBeat Week in Review – 10/16 - 10/20

All the major indexes moved lower on Friday, making it a near certainty that stocks would post their worst week in a month; the bears are firmly in control

HRL : 30.55 (+0.39%)
CPB : 45.53 (+0.57%)
LMND : 16.07 (-2.37%)
UAA : 6.44 (-1.08%)
VFS : 4.05 (-2.64%)
TSLA : 231.26 (+10.20%)
TXN : 198.42 (+1.96%)
META : 509.50 (+0.96%)
DLTR : 107.11 (-0.13%)
NFLX : 679.58 (+0.89%)
DXCM : 112.49 (+0.29%)
TPST : 2.12 (-0.93%)
Exploring What Led to a 3,000% Surge in Shares of Tempest Therapeutics (NASDAQ: TPST)

Tempest Therapeutics, Inc. (NASDAQ: TPST) recently captivated investors with an unprecedented surge of over 3,000% in less than a week.

TPST : 2.12 (-0.93%)
Navigating the Roller Coaster of Recent Penny Stock Surges

Recent surges in penny stocks, like Secoo (SECO), Tempest Therapeutics (TPST), and OpGen (OPGN), have fueled speculation and excitement in penny stocks.

SECO : 0.4049 (+5.17%)
OPGN : 2.62 (+4.67%)
TPST : 2.12 (-0.93%)
Tempest Therapeutics (NASDAQ: TPST) Reports Strong Early Results From Phase 1b/2 Study of TPST-1120 in Hepatocellular Carcinoma

Tempest Therapeutics, Inc. (NASDAQ: TPST) is engaged as a clinical-stage oncology company, which is focused on the research and development

TPST : 2.12 (-0.93%)
Tempest to Participate in Panel Discussion at 2022 William Blair Biotech Focus Conference

President Tom Dubensky, Ph.D., to Share Expertise on Next Generation Immuno-Oncolgy Targets...

TPST : 2.12 (-0.93%)
Tempest to Present at the Jefferies Healthcare Conference

SOUTH SAN FRANCISCO, Calif., June 06, 2022 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage oncology company developing...

TPST : 2.12 (-0.93%)
Tempest Reports Positive TPST-1120 Clinical Data from Phase 1 Trial in Patients with Advanced Solid Tumors at 2022 ASCO Annual Meeting

RECIST responses observed in IO-refractory patients and in IO-resistant indications 30% ORR in patients treated at the two highest TPST-1120 doses in...

TPST : 2.12 (-0.93%)
Tempest Reports First Quarter 2022 Financial Results and Provides Corporate Highlights

Announced oral presentation of TPST-1120 Phase 1 monotherapy and combination therapy data at ASCOPresented positive preclinical data for TPST-1495 at...

TPST : 2.12 (-0.93%)
Tempest Announces Oral and Poster Presentations at the Upcoming 2022 ASCO Annual Meeting

Oral presentation for TPST-1120 completed Phase 1 trial resultsPoster presentation for TPST-1495 trial in progress SOUTH SAN FRANCISCO, Calif., April 27,...

TPST : 2.12 (-0.93%)

Business Summary

Tempest Therapeutics Inc. is a clinical-stage oncology company developing potentially first-in-class therapeutics which combines both targeted and immune-mediated mechanisms. Tempest Therapeutics Inc., formerly known as Millendo Therapeutics Inc., is based in Calif.

See More

Key Turning Points

3rd Resistance Point 2.28
2nd Resistance Point 2.23
1st Resistance Point 2.18
Last Price 2.12
1st Support Level 2.07
2nd Support Level 2.02
3rd Support Level 1.97

See More

52-Week High 9.77
Fibonacci 61.8% 6.10
Fibonacci 50% 4.97
Fibonacci 38.2% 3.84
Last Price 2.12
52-Week Low 0.17

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar